Matinas Biopharma Holdings Inc share price logo

Matinas Biopharma Holdings Inc Share Price

NYSE: MTNB

Small Cap

$1.85

+0.05

(+2.78%)

as on

Matinas Biopharma Holdings Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.76
    $1.88
    downward going graph

    4.86%

    Downside

    1.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.47
    $4.25
    downward going graph

    74.34%

    Downside

    129.73%

    Upside

    downward going graph

Matinas Biopharma Holdings Inc share price movements today

Previous Close
$1.80
Open
$1.81
Volume
232.6K
Day's Low - High
$1.76 - $1.88
52 Week Low - High
$0.47 - $4.25

Matinas Biopharma Holdings Inc Historical Returns

1 Month Return
+ 17.31 %
3 Month Return
+ 117.86 %
1 Year Return
-52.34 %
3 Year Return
-94.85 %
5 Year Return
-94.72 %

Matinas Biopharma Holdings Inc Stock Fundamentals & Key Indicators

Check Matinas Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.0M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.02

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-12.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

41853100.00%

Matinas Biopharma Holdings Inc Stock Valuation

Track how Matinas Biopharma Holdings Inc P/E has moved over time to understand its valuation trends.

Matinas Biopharma Holdings Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 13, 2025

Industry (0.00x)

September 13, 2025

Today (-1.02x)

September 13, 2025

Highest (-0.18x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.02x

Matinas Biopharma Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Matinas Biopharma Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$10.0M-94.72%-1.020.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Matinas Biopharma Holdings Inc Stock including INR - Dollar returns

The Matinas Biopharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Matinas Biopharma Holdings Inc investment value today

Current value as on today

₹53,316

Returns

₹46,684

(-46.68%)

Returns from Matinas Biopharma Holdings Inc Stock

₹51,823 (-51.82%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Matinas Biopharma Holdings Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Matinas Biopharma Holdings Inc. Average target price of $30

Matinas Biopharma Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Matinas Biopharma Holdings Inc.

What analysts predicted

93.83%UPSIDE

Target Price

$30

Current Price

$1.85

Analyzed by

9 Analysts

Target

$30.00

Matinas Biopharma Holdings Inc target price $30, a slight upside of 93.83% compared to current price of $1.85. According to 9 analysts rating.

Matinas Biopharma Holdings Inc Stock's Interest Amongst Investors

Investment in Matinas Biopharma Holdings Inc Shares on INDmoney has grown by 546.15% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:546.15% versus previous 30 day period

Search interest for Matinas Biopharma Holdings Inc Stock has increased by 454% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:454% versus previous 30 day period

Matinas Biopharma Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
-
-
-1
-
-
-
-
0
-
Gross Profit
0
0
0
-1
0
0
0
-
0
0
Operating Income
-5
-6
-6
-5
-5
-5
-4
-4
-1
-1
EBITDA
-5
-5
-5
-5
-5
-5
-4
-
-1
-1
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-6
-6
-5
-5
-5
-4
-8
-1
-5
Income Tax Expense
0
0
0
0
0
-
-
-
0
-
Net Income
-5
-6
-6
-5
-5
-5
-4
-8
-1
-5
Net Profit Margin
-496.35%
0.00%
0.00%
484.85%
0.00%
0.00%
0.00%
0.00%
-172.14%
0.00%

Matinas Biopharma Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
-
0
0
0
0
0
3
1
-
Gross Profit
-5
0
-8
-6
-11
-14
0
-13
-13
0
Operating Income
-9
-8
-16
-14
-18
-24
-24
-24
-23
-20
EBITDA
-9
-8
-16
-14
-18
-23
-24
-24
-22
-23
Interest Expense
-
-
-
-
-
-
1
3
-
-
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-9
-7
-15
-14
-17
-22
-23
-20
-22
-24
Income Tax Expense
0
0
0
0
-1
-1
-2
-7
0
0
Net Income
-9
-7
-15
-14
-15
-20
-21
-13
-22
-24
Net Profit Margin
-4697.01%
0.00%
-10345.91%
-11760.39%
-17316.87%
-13009.90%
-63521.00%
-408.25%
-2093.25%
0.00%

Matinas Biopharma Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-6
-6
-5
-5
-5
-4
-8
-1
-5
Operating Cash Flow
-2
-4
-4
-5
-3
-3
-3
-2
-2
Investing Cash Flow
6
1
2
2
-2
9
-
0
-
Financing Cash Flow
0
0
0
0
9
0
0
1
1
Change in Cash
4
-3
-1
-3
3
6
-3
0
0

Matinas Biopharma Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-7
-15
-14
-17
-22
-23
-20
-22
-24
Operating Cash Flow
-6
-11
-10
-14
-17
-15
-19
-15
-15
Investing Cash Flow
0
0
0
-6
-40
16
4
13
9
Financing Cash Flow
6
15
15
29
48
6
0
0
9
Change in Cash
0
3
5
9
-9
8
-14
-2
2

Insights on Matinas Biopharma Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MTNB stock has moved up by 20.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -1.09M → 962.0K (in $), with an average increase of 213.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 126.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 220.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.65M → -5.24M (in $), with an average decrease of 216.7% per quarter

About Matinas Biopharma Holdings Inc

matinas biopharma (nyse mkt: mtnb) is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. the company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. the company's lead drug candidate mat2203, currently in phase 2, is an orally-administered, encochleated formulation of amphotericin b (a broad spectrum fungicidal agent). the company has an open investigational new drug (ind) application for mat2501, currently in phase 1, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) for acute bacterial infections, including non-tuberculous mycobacterium (ntm) and multi-drug resistant gram negative bacterial infections. the company's lead anti-infective product candidates, mat2203 and mat2501, position matinas biopharma to bec
OrganisationMatinas Biopharma Holdings Inc
Headquarters1545 Route 206 South, Bedminster, NJ, United States, 07921
IndustryHealth Technology
CEOMr. Jerome D. Jabbour J.D.
E-voting on sharesClick here to vote

Key Management of Matinas Biopharma Holdings Inc

Name

Title

Mr. Jerome D. Jabbour J.D.

Co-Founder, Chairman, CEO and President

Mr. Keith A. Kucinski CPA, M.B.A.

Chief Financial Officer

FAQs

What is Matinas Biopharma Holdings Inc share price today?

Matinas Biopharma Holdings Inc share price today is $1.85 as on at the close of the market. Matinas Biopharma Holdings Inc share today touched a day high of $1.88 and a low of $1.76.

What is the 52 week high and 52 week low for Matinas Biopharma Holdings Inc share?

Matinas Biopharma Holdings Inc share touched a 52 week high of $4.25 on and a 52 week low of $0.47 on . Matinas Biopharma Holdings Inc stock price today i.e. is closed at $1.85,which is 56.47% down from its 52 week high and 289.64% up from its 52 week low.

What is Matinas Biopharma Holdings Inc's market capitalisation today?

Matinas Biopharma Holdings Inc market capitalisation is $0.00T as on .

How to invest in Matinas Biopharma Holdings Inc Stock (MTNB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Matinas Biopharma Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Matinas Biopharma Holdings Inc Shares that will get you 0.8108 shares as per Matinas Biopharma Holdings Inc share price of $1.85 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Matinas Biopharma Holdings Inc Stock (MTNB) from India?

Indian investors can start investing in Matinas Biopharma Holdings Inc (MTNB) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Matinas Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Matinas Biopharma Holdings Inc share’s latest price of $1.85 as on September 13, 2025 at 1:29 am IST, you will get 5.4054 shares of Matinas Biopharma Holdings Inc. Learn more about fractional shares .

What are the returns that Matinas Biopharma Holdings Inc has given to Indian investors in the last 5 years?

Matinas Biopharma Holdings Inc stock has given -94.72% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?